Impact of Dolutegravir-, Lopinavir/Ritonavir-, and Efavirenz-Based Antiretrovirals on Piperaquine Pharmacokinetics in Ugandan Children Living with HIV.

Kajubi R, Koire M, Whalen ME, Orukan F, Okiring J, Marzan F, Richards K, Lier AJ, Goodwin J, Colt M, Pham X, He S, Chu DHT, Opira B, Kisitu GP, Sekabira R, Kekitiinwa A, Huynh D, Khoury M, Gallison K, Fotaki N, Mwima MW, Kamya MR, Aweeka FT, Parikh S, Huang L, Mwebaza N

Open source

DOI: 10.1002/cpt.70393
Published: 2026 Jul 17
Container: Clinical pharmacology and therapeutics
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/cpt.70393,
  title = {Impact of Dolutegravir-, Lopinavir/Ritonavir-, and Efavirenz-Based Antiretrovirals on Piperaquine Pharmacokinetics in Ugandan Children Living with HIV.},
  author = {Kajubi R and Koire M and Whalen ME and Orukan F and Okiring J and Marzan F and Richards K and Lier AJ and Goodwin J and Colt M and Pham X and He S and Chu DHT and Opira B and Kisitu GP and Sekabira R and Kekitiinwa A and Huynh D and Khoury M and Gallison K and Fotaki N and Mwima MW and Kamya MR and Aweeka FT and Parikh S and Huang L and Mwebaza N},
  year = {2026},
  journal = {Clinical pharmacology and therapeutics},
  doi = {10.1002/cpt.70393},
  url = {https://doi.org/10.1002/cpt.70393}
}

RIS

TY  - JOUR
TI  - Impact of Dolutegravir-, Lopinavir/Ritonavir-, and Efavirenz-Based Antiretrovirals on Piperaquine Pharmacokinetics in Ugandan Children Living with HIV.
AU  - Kajubi R
AU  - Koire M
AU  - Whalen ME
AU  - Orukan F
AU  - Okiring J
AU  - Marzan F
AU  - Richards K
AU  - Lier AJ
AU  - Goodwin J
AU  - Colt M
AU  - Pham X
AU  - He S
AU  - Chu DHT
AU  - Opira B
AU  - Kisitu GP
AU  - Sekabira R
AU  - Kekitiinwa A
AU  - Huynh D
AU  - Khoury M
AU  - Gallison K
AU  - Fotaki N
AU  - Mwima MW
AU  - Kamya MR
AU  - Aweeka FT
AU  - Parikh S
AU  - Huang L
AU  - Mwebaza N
PY  - 2026
JO  - Clinical pharmacology and therapeutics
DO  - 10.1002/cpt.70393
UR  - https://doi.org/10.1002/cpt.70393
ER  -

APA

R, K., M, K., ME, W., F, O., J, O., F, M., K, R., AJ, L., J, G., M, C., X, P., S, H., DHT, C., B, O., GP, K., R, S., A, K., D, H., M, K., K, G., N, F., MW, M., MR, K., FT, A., S, P., L, H., & N, M. (2026). Impact of Dolutegravir-, Lopinavir/Ritonavir-, and Efavirenz-Based Antiretrovirals on Piperaquine Pharmacokinetics in Ugandan Children Living with HIV.. Clinical pharmacology and therapeutics. https://doi.org/10.1002/cpt.70393

Source records

pubmed · retrieved 2026-09-25T04:25:55.212Z
europe-pmc · retrieved 2026-09-25T04:25:55.246Z